Bifogade filer
Elekta Q1 Report 2024 2025 ENG
Kurs
+0,80%
Kurs
+0,80%
Open
75,00
High
76,30
Low
69,35
Close
69,60
Kursutveckling under dagen för detta pressmeddelande
(SEK).
Likviditet
1 148 MSEK
Likviditet
1 148 MSEK
Rel. mcap
4,74%
Antal aktier
15 857 197
Likviditet under dagen för detta pressmeddelande
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Elekta AB (publ) via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Ett email har skickats till adressen, bekräfta det för att slutföra prenumerationen.
Du har prenumererat
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Kalender
| Tid* | ||
| 2025-05-28 | 07:30 | Bokslutskommuniké 2025 |
| 2025-02-21 | 07:30 | Kvartalsrapport 2025-Q3 |
| 2024-11-27 | 07:30 | Kvartalsrapport 2025-Q2 |
| 2024-09-06 | - | X-dag halvårsutdelning EKTA B 1.2 |
| 2024-09-05 | - | Årsstämma |
| 2024-08-28 | - | Kvartalsrapport 2025-Q1 |
| 2024-06-05 | - | Bokslutskommuniké 2024 |
| 2024-02-29 | - | Kvartalsrapport 2024-Q3 |
| 2024-02-26 | - | X-dag halvårsutdelning EKTA B 1.2 |
| 2023-11-30 | - | Kvartalsrapport 2024-Q2 |
| 2023-08-25 | - | X-dag halvårsutdelning EKTA B 1.2 |
| 2023-08-24 | - | Årsstämma |
| 2023-08-24 | - | Kvartalsrapport 2024-Q1 |
| 2023-05-25 | - | Bokslutskommuniké 2023 |
| 2023-02-24 | - | Kvartalsrapport 2023-Q3 |
| 2023-02-24 | - | X-dag halvårsutdelning EKTA B 1.2 |
| 2022-11-24 | - | Kvartalsrapport 2023-Q2 |
| 2022-08-26 | - | X-dag halvårsutdelning EKTA B 1.2 |
| 2022-08-25 | - | Årsstämma |
| 2022-08-25 | - | Kvartalsrapport 2023-Q1 |
| 2022-05-25 | - | Bokslutskommuniké 2022 |
| 2022-02-24 | - | Kvartalsrapport 2022-Q3 |
| 2022-02-24 | - | X-dag halvårsutdelning EKTA B 1.1 |
| 2021-11-25 | - | Kvartalsrapport 2022-Q2 |
| 2021-08-26 | - | X-dag halvårsutdelning EKTA B 1.1 |
| 2021-08-25 | - | Årsstämma |
| 2021-08-25 | - | Kvartalsrapport 2022-Q1 |
| 2021-05-28 | - | Bokslutskommuniké 2021 |
| 2021-04-19 | - | X-dag bonusutdelning EKTA B 0.9 |
| 2021-04-16 | - | Extra Bolagsstämma 2021 |
| 2021-02-25 | - | Kvartalsrapport 2021-Q3 |
| 2020-11-26 | - | Kvartalsrapport 2021-Q2 |
| 2020-08-27 | - | X-dag halvårsutdelning EKTA B 0.9 |
| 2020-08-26 | - | Årsstämma |
| 2020-08-26 | - | Kvartalsrapport 2021-Q1 |
| 2020-05-29 | - | Bokslutskommuniké 2020 |
| 2020-02-21 | - | X-dag halvårsutdelning EKTA B 0.9 |
| 2020-02-20 | - | Kvartalsrapport 2020-Q3 |
| 2019-11-28 | - | Kvartalsrapport 2020-Q2 |
| 2019-08-23 | - | X-dag halvårsutdelning EKTA B 0.9 |
| 2019-08-22 | - | Årsstämma |
| 2019-08-22 | - | Kvartalsrapport 2020-Q1 |
| 2019-05-29 | - | Bokslutskommuniké 2019 |
| 2019-03-01 | - | X-dag halvårsutdelning EKTA B 0.7 |
| 2019-02-22 | - | Kvartalsrapport 2019-Q3 |
| 2018-11-29 | - | Kvartalsrapport 2019-Q2 |
| 2018-08-31 | - | X-dag halvårsutdelning EKTA B 0.7 |
| 2018-08-30 | - | Årsstämma |
| 2018-08-30 | - | Kvartalsrapport 2019-Q1 |
| 2018-06-01 | - | Bokslutskommuniké 2018 |
| 2018-03-02 | - | Kvartalsrapport 2018-Q3 |
| 2018-02-22 | - | X-dag halvårsutdelning EKTA B 0.5 |
| 2017-11-30 | - | Kvartalsrapport 2018-Q2 |
| 2017-08-24 | - | X-dag halvårsutdelning EKTA B 0.5 |
| 2017-08-23 | - | Årsstämma |
| 2017-08-23 | - | Kvartalsrapport 2018-Q1 |
| 2017-06-01 | - | Bokslutskommuniké 2017 |
| 2017-03-03 | - | X-dag halvårsutdelning EKTA B 0.25 |
| 2017-03-01 | - | Kvartalsrapport 2017-Q3 |
| 2016-12-01 | - | Kvartalsrapport 2017-Q2 |
| 2016-09-26 | - | Kapitalmarknadsdag 2016 |
| 2016-09-02 | - | X-dag halvårsutdelning EKTA B 0.25 |
| 2016-09-01 | - | Årsstämma |
| 2016-09-01 | - | Kvartalsrapport 2017-Q1 |
| 2016-06-01 | - | Bokslutskommuniké 2016 |
| 2016-03-02 | - | Kvartalsrapport 2016-Q3 |
| 2015-12-03 | - | Kvartalsrapport 2016-Q2 |
| 2015-09-02 | - | X-dag ordinarie utdelning EKTA B 0.50 SEK |
| 2015-09-01 | - | Årsstämma |
| 2015-09-01 | - | Kvartalsrapport 2016-Q1 |
| 2015-06-02 | - | Bokslutskommuniké 2015 |
| 2015-03-04 | - | Kvartalsrapport 2015-Q3 |
| 2014-11-27 | - | Kvartalsrapport 2015-Q2 |
| 2014-11-27 | - | Analytiker möte 2014 |
| 2014-09-15 | - | Kapitalmarknadsdag 2014 |
| 2014-08-29 | - | X-dag ordinarie utdelning EKTA B 1.50 SEK |
| 2014-08-29 | - | X-dag bonusutdelning EKTA B 0.5 |
| 2014-08-28 | - | Årsstämma |
| 2014-08-28 | - | Kvartalsrapport 2015-Q1 |
| 2014-08-28 | - | Analytiker möte 2015 |
| 2014-05-28 | - | Bokslutskommuniké 2014 |
| 2014-05-28 | - | Analytiker möte 2014 |
| 2014-02-27 | - | Kvartalsrapport 2014-Q3 |
| 2013-12-04 | - | Kvartalsrapport 2014-Q2 |
| 2013-09-23 | - | Kapitalmarknadsdag 2013 |
| 2013-09-04 | - | X-dag ordinarie utdelning EKTA B 1.50 SEK |
| 2013-09-04 | - | X-dag bonusutdelning EKTA B 0.5 |
| 2013-09-03 | - | Årsstämma |
| 2013-09-03 | - | Kvartalsrapport 2014-Q1 |
| 2013-06-05 | - | Bokslutskommuniké 2013 |
| 2013-06-05 | - | Analytiker möte 2013 |
| 2013-03-05 | - | Extra Bolagsstämma 2013 |
| 2013-03-05 | - | Kvartalsrapport 2013-Q3 |
| 2012-12-04 | - | Kvartalsrapport 2013-Q2 |
| 2012-10-29 | - | Kapitalmarknadsdag 2012 |
| 2012-09-12 | - | Split EKTA B 1:4 |
| 2012-09-05 | - | X-dag ordinarie utdelning EKTA B 5.00 SEK |
| 2012-09-03 | - | Årsstämma |
| 2012-09-03 | - | Kvartalsrapport 2013-Q1 |
| 2012-06-05 | - | Bokslutskommuniké 2012 |
| 2012-06-05 | - | Analytiker möte 2012 |
| 2012-04-02 | - | Extra Bolagsstämma 2012 |
| 2012-03-05 | - | Kvartalsrapport 2012-Q3 |
| 2011-12-02 | - | Kvartalsrapport 2012-Q2 |
| 2011-09-14 | - | X-dag ordinarie utdelning EKTA B 4.00 SEK |
| 2011-09-13 | - | Årsstämma |
| 2011-09-13 | - | Kvartalsrapport 2012-Q1 |
| 2011-06-09 | - | Bokslutskommuniké 2011 |
| 2011-03-08 | - | Kvartalsrapport 2011-Q3 |
| 2010-12-07 | - | Kvartalsrapport 2011-Q2 |
| 2010-09-22 | - | X-dag ordinarie utdelning EKTA B 3.00 SEK |
| 2010-09-21 | - | Kvartalsrapport 2011-Q1 |
| 2010-06-09 | - | Bokslutskommuniké 2010 |
| 2010-03-10 | - | Kvartalsrapport 2009-Q3 |
| 2009-12-10 | - | Kvartalsrapport 2009-Q2 |
| 2009-09-16 | - | X-dag ordinarie utdelning EKTA B 2.00 SEK |
| 2009-09-15 | - | Årsstämma |
| 2009-09-15 | - | Kvartalsrapport 2009-Q1 |
| 2008-09-19 | - | X-dag ordinarie utdelning EKTA B 1.75 SEK |
| 2007-09-26 | - | X-dag ordinarie utdelning EKTA B 1.00 SEK |
| 2006-09-21 | - | X-dag ordinarie utdelning EKTA B 1.00 SEK |
| 2005-10-17 | - | Split EKTA B 1:3 |
| 2005-09-22 | - | X-dag ordinarie utdelning EKTA B 6.60 SEK |
| 2004-09-22 | - | X-dag ordinarie utdelning EKTA B 0.00 SEK |
| 2003-09-23 | - | X-dag ordinarie utdelning EKTA B 0.00 SEK |
| 2002-10-01 | - | X-dag ordinarie utdelning EKTA B 0.00 SEK |
| 2001-09-28 | - | X-dag ordinarie utdelning EKTA B 0.00 SEK |
| 2000-10-02 | - | X-dag ordinarie utdelning EKTA B 0.00 SEK |
| 1999-09-23 | - | X-dag ordinarie utdelning EKTA B 0.00 SEK |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2024-08-28 07:30:00
First quarter
- In constant exchange rates, net sales increased by 1 percent mainly driven by North America. Reported sales were unchanged amounting to SEK 3,825 M (3,828).
- The book-to-bill ratio improved to 1.10 (1.00), supporting future revenue growth.
- Adjusted gross margin amounted to 37.8 percent (41.6). A sequential increase of 120 basis points was supported by an improved service margin.
- Adjusted EBIT amounted to SEK 283 M (427), corresponding to a margin of 7.4 percent (11.2). This was a result of increased operating expenses driven by higher amortization following recent product launches.
- Net income was SEK 71 M (238) and earnings per share diluted was SEK 0.18 (0.62).
- Cash flow after continuous investments amounted to SEK -891 M (-900). Lower earnings were compensated by improved working capital.
- Net sales for Elekta are expected to grow by mid-single digit for the full year of 2024/25 with an improved EBIT margin supported by the recent product launch Elekta Evo.
| Group summary | Q1 | 12 months | ||||||
| SEK M | 2024/25 | 2023/24 | Δ | RTM | 2023/24 | Δ | ||
| Book-to-bill | 1,10 | 1,00 | 9% | 1,11 | 1,09 | 2% | ||
| Net sales | 3,825 | 3,828 | 0% | 18,117 | 18,119 | 0% | ||
| Net sales in constant exchange rates | 1% | 1 | 5% | 2 | ||||
| Adjusted gross margin 3 | 37.8% | 41.6% | -3,8 ppts | 36.7% | 37.5% | -0.8 ppts | ||
| Adjusted EBITDA 4 | 600 | 707 | -15% | 3,180 | 3,287 | -3% | ||
| Adjusted EBITDA margin 4 | 15.7% | 18.5% | -2.8 ppts | 17.6% | 18.1% | -0.6 ppts | ||
| Adjusted EBIT 5 | 283 | 427 | -34% | 2,001 | 2,145 | -7% | ||
| Adjusted EBIT margin 5 | 7.4% | 11.2% | -3.8 ppts | 11.0% | 11.8% | -0.8 ppts | ||
| Gross margin | 37.0% | 41.5% | -4.5 ppts | 36.5% | 37.4% | -0.9 ppts | ||
| EBITDA | 522 | 693 | -25% | 3,018 | 3,189 | -5% | ||
| EBITDA margin | 13.6% | 18.1% | -4.5 ppts | 16.7% | 17.6% | -0.9 ppts | ||
| EBIT | 174 | 412 | -58% | 1,801 | 2,039 | -12% | ||
| EBIT margin | 4.5% | 10.8% | -6.2 ppts | 9.9% | 11.3% | -1.3 ppts | ||
| Net income | 71 | 238 | -70% | 1,135 | 1,302 | -13% | ||
| Cash flow after continuous investments | -891 | -900 | 9 | 824 | 815 | 9 | ||
| Adjusted earnings per share before/after dilution, SEK 6 | 0.41 / 0.41 | 0.65 / 0.65 | -38% | 3.38 / 3.38 | 3.62 / 3.62 | -7% | ||
| Earnings per share before/after dilution, SEK | 0.18 / 0.18 | 0.62 / 0.62 | -70% | 2.97 / 2.97 | 3.41 / 3.41 | -13% | ||
1 Compared to last fiscal year based on constant exchange rates.
2 Compared to last rolling twelve months period Aug 2022 – Jul 2023 based on constant currency.
3 Adjusted gross margin = Gross margin excluding items affecting comparability attributable to the Cost-reduction Initiative, see page 25.
4 Adjusted EBITDA = EBITDA excluding items affecting comparability attributable to the Cost-reduction Initiative, see page 25.
5 Adjusted EBIT = Operating income (EBIT) excluding items affecting comparability, see page 26.
6 Adjusted earnings per share = Net income excluding items affecting comparability, attributable to Parent Company shareholders, in relation to the weighted average number of shares (excluding treasury shares), see page 27.
Further actions to improve profitability
We continue to take action to improve profitability and we are starting to see positive signs. We have increased prices, starting to be visible in this quarter, with more to come. Our recent product launches are expected to have a positive impact on margins and sales later in the fiscal year. Elekta Evo, our latest linear accelerator, has been well received by customers, relating to clinical needs and elevating personalized care as well as increased productivity. We continue to drive cost-reduction initiatives with the target to generate annual cost savings by around SEK 250 M at the end of the fiscal year.
Gustaf Salford
President and CEO
This information is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-08-28 07:30 CEST.